Research Use Only. Not an approved medicine and not for human use. Educational only — no dosing or medical advice.
What it is
A proprietary oral stack combining Dihexa (an angiotensin-derived pro-cognitive peptide), methylene blue, and tesofensine. See component notes; Dihexa itself is preclinical.
Proposed mechanism
Dihexa is studied preclinically for synaptogenesis (HGF/c-Met pathway); methylene blue for mitochondrial/redox effects; tesofensine as an appetite-suppressing reuptake inhibitor. Combining them is not studied as a unit.1 Note methylene blue's dangerous serotonergic interactions.
State of the evidence
No blend trials; component evidence ranges from preclinical (Dihexa) to Phase 2 (tesofensine).
Regulatory & status
Not approved as a blend; components are RUO/investigational. Serotonergic interaction risk (methylene blue).
For educational and research purposes only. This content is not medical advice. Contains methylene blue, which has dangerous drug interactions; use only under a licensed professional. Free Peptide University does not sell compounds.